Aldeyra Therapeutics Inc (ALDX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

131 HARTWELL AVENUE LEXINGTON, MA 02421

Aldeyra Therapeutics, Inc. develops drugs designed to treat immune-mediated, inflammatory, orphan, and other diseases through capturing and eradicating toxic chemical species within effected patients.

Data as of 2021-05-08 11:28:25 -0400
Market Cap719.237 Million Shares Outstanding57.631 Million Avg 30-day Volume5.505 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-10.88 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.84928 52-week High/Low15.95 / 2.8 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ALDX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 5 -60.0% 0 (0.0%) 3 (0.19%) -100.0%
Funds Holding: 97 86 12.79% 31 (1.86%) 30 (1.87%) 3.33%
13F shares: 22.384 Million 23.793 Million -5.92% 15.595 Million 16.891 Million -7.67%
% Ownership 57.6595 61.2905 -5.92% 40.1732 43.5096 -7.67%
New Positions: 24 23 4.35% 8 6 33.33%
Increased Positions 28 28 0.0% 12 13 -7.69%
Closed Positions 12 21 -42.86% 6 8 -25.0%
Reduced Positions 24 21 14.29% 9 8 12.5%
Total Calls 105.639 Thousand 120.734 Thousand -12.5% 24 Thousand 23.4 Thousand 2.56%
Total Puts 308.103 Thousand 36.759 Thousand 738.17% 214 Thousand 0
PUT/CALL Ratio 2.92 0.3 873.33% 8.92 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ALDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALDX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1.2 Million total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
9,903,879 2021-05-03 1

BRADY TODD C PRESIDENT AND CEO

  • Officer
  • Director
1,198,835 2021-04-12 1

REED JOSHUA CHIEF FINANCIAL OFFICER

  • Officer
150,185 2021-04-12 1

MACHATHA STEPHEN CHIEF DEVELOPMENT OFFICER

  • Officer
116,201 2021-04-12 2

WALKER NEAL

  • Director
0 2020-06-09 1

JOYCE MARTIN JOSEPH

  • Director
0 2020-06-09 1

BRONSTEIN BEN

  • Director
0 2020-06-09 1

PHILLIPS GARY M.

  • Director
0 2020-06-09 1

TREU JESSE I

  • Director
0 2020-06-09 1

DOUGLAS RICHARD

  • Director
0 2020-06-09 1

MILLER-RICH NANCY

  • Director
0 2020-06-09 1

MCMULLIN DAVID CHIEF COMMERCIAL OFFICER

  • Officer
255,183 2020-03-02 0

CLARK DAVID J CHIEF MEDICAL OFFICER

  • Officer
17,878 2019-09-06 0

TULIPANO STEPHEN J CHIEF FINANCIAL OFFICER

  • Officer
8,563 2018-03-06 0

CLARKE C. BOYD

  • Director
0 2016-06-09 0

YOUNG SCOTT CHIEF OPERATING OFFICER

  • Officer
0 2016-03-16 0

SHAH NIMESH

  • 10% Owner
10,358 2015-01-01 0

DOMAIN PARTNERS VI, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

  • Director
  • 10% Owner
1,973,389 2014-05-07 0

JOHNSON & JOHNSON

JOHNSON & JOHNSON DEVELOPMENT CORP ET AL

  • 10% Owner
1,750,292 2014-05-01 0

DOMAIN ASSOCIATES

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

KAMDAR KIM P.

  • Director
  • 10% Owner
10,358 2014-05-01 0

DP VI ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

  • Director
  • 10% Owner
9,208 2014-05-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PERCEPTIVE ADVISORS LLC - > 10% Owner see footnote

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD - > 10% Owner see footnote

EDELMAN JOSEPH - > 10% Owner see footnote

2021-05-04 17:55:35 -0400 2021-05-03 P 1,200,000 $12.50 a 9,903,879 indirect 0.6683 0.6683 2 0.0 1

BRADY TODD C - Director - Officer PRESIDENT AND CEO

2021-04-14 19:23:43 -0400 2021-04-12 A 46,619 a 948,835 direct -2.5065 -9.7666 2.3336 5 -9.7666 6

REED JOSHUA - Officer CHIEF FINANCIAL OFFICER

2021-04-14 19:25:29 -0400 2021-04-12 A 150,185 a 150,185 direct

BRADY TODD C - Director - Officer PRESIDENT AND CEO

2021-04-14 19:23:43 -0400 2021-04-12 A 250,000 a 250,000 direct

MACHATHA STEPHEN - Officer CHIEF DEVELOPMENT OFFICER

2021-04-14 19:24:10 -0400 2021-04-12 A 116,201 a 116,201 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 22:15:04 UTC -0.5439 0.5939 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 21:45:02 UTC -0.5439 0.5939 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 21:15:02 UTC -0.5439 0.5939 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 20:45:03 UTC -0.5431 0.5931 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 20:15:03 UTC -0.5431 0.5931 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 19:45:03 UTC -0.5431 0.5931 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 19:15:03 UTC -0.5431 0.5931 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 18:45:03 UTC -0.5457 0.5957 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 18:15:03 UTC -0.5457 0.5957 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 17:45:02 UTC -0.5457 0.5957 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 17:15:03 UTC -0.5457 0.5957 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 16:45:03 UTC -0.5457 0.5957 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 16:15:03 UTC -0.5457 0.5957 1600000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 15:45:03 UTC -0.5457 0.5957 1500000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 15:15:03 UTC -0.5457 0.5957 1400000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 14:45:04 UTC -0.5457 0.5957 1400000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 14:15:04 UTC -0.5457 0.5957 1400000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 13:45:04 UTC -0.5457 0.5957 1400000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 13:15:03 UTC -0.5457 0.5957 1400000
ALDEYRA THERAPEUTICS INC ALDX 2021-05-10 12:45:02 UTC -0.5457 0.5957 1400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments